Women are turning to GLP-1 medications for weight loss, metabolic health, and PCOS support. But many are noticing something else, too: their bodies are changing in ways they didn’t expect – and don’t fully understand.
What we did
To better understand this emerging pattern, Mira conducted a survey of 310 women who use the Mira hormone monitor and were using GLP-1 medications such as Ozempic®, Wegovy®, Mounjaro®, Zepbound®, and others.
The goal was simple: to explore how these medications may be connected to changes in cycles, ovulation, hormones, and overall wellbeing.
What we found was clear – and complex: Something is changing. But it’s not happening the same way for everyone.
“I started GLP-1, but no one explained how it might affect my cycle.”
“I don’t know what it’s doing to my hormones – I just know something is changing.”
“There’s no clear guidance on what’s normal.”
– Mira survey participants
That sentiment showed up again and again.
-
58% of women reported changes in their cycle, ovulation, libido, or related symptoms
-
40% said they felt confused about what was happening in their body
-
41% were not aware before starting that GLP-1 could affect their cycle or fertility
This points to a growing gap: women are experiencing real changes — without clear guidance on how to interpret them.
GLP-1 and menstrual cycles: common, but not predictable changes
For many women, the first noticeable shift is their cycle.
Some describe it as improvement. Others experience disruption.
What women reported:
-
57% said their cycles became more regular
-
24% reported lighter periods
-
Around 13% experienced more irregular cycles, heavier periods, or missed periods
“Some things improved, some got worse.”
– Mira survey participant
What this means
GLP-1 medications may influence hormonal patterns – but effects move in different directions and outcomes are not uniform.
For some, it feels like their body is “stabilizing.”
For others, it feels like something is shifting without a clear pattern.
Ovulation: improvement for some, variability for others
Ovulation is one of the most important – and most uncertain – areas.
What women reported:
-
14% started ovulating after previously not ovulating
-
24% reported more predictable ovulation
-
26% saw clearer hormone patterns around ovulation
-
Around 20% experienced timing shifts (earlier or later ovulation)
-
4% stopped ovulating
The underlying tension was:
“Is this helping my fertility or affecting it?”
– Mira survey participant
This question reflects the broader reality. GLP-1 may support ovulation patterns for some, but introduce variability for others.
GLP-1 and PCOS: where changes feel strongest
Among all groups, women with PCOS reported the most pronounced shifts.
What women with PCOS reported
-
74% noticed changes in cycle regularity
-
43% noticed changes in cycle predictability
-
57.5% reported changes in PCOS-related symptoms
What this suggests
GLP-1 medications are increasingly discussed in the context of PCOS – particularly due to links with insulin resistance.
And based on the survey, many women report improvements.
But results are not guaranteed, responses remain individual.
Which raises a key question: who benefits – and how can you understand what’s changing in your own body?
The “unexpected effects”: it’s not just about weight
One of the strongest insights from the survey: 1 in 5 women said cycle changes were the most unexpected effect.
But cycles weren’t the only thing shifting.
Libido: moving in both directions
-
35% reported no change
-
29% reported higher libido
-
19% reported lower libido
Body confidence and sex life
-
70% of women reported improvements in body confidence and sex life
Mood and lifestyle changes
-
45% said their mood became more stable
-
53% lost interest in foods they previously enjoyed
-
49% reported reduced desire to drink alcohol
What this tells us
GLP-1 may influence behavior, emotional state, habits.
But again: the experience is highly individual.
The biggest gap: understanding
The most consistent insight wasn’t the changes themselves.
It was the lack of clarity around them.
What women want to understand
-
59% want to understand how GLP-1 affects their chances of pregnancy
-
56% want clarity on hormone changes
-
51% want to understand ovulation changes
How women are trying to figure it out
Instead of structured guidance, many women are self-navigating:
-
38% track hormones or symptoms
-
37% search online
-
30% use AI tools
-
Only 22% ask doctors
Women are actively trying to decode what’s happening in their bodies — often without clear support.
A new reality: GLP-1 as a personal experiment
Many women describe their experience as:
-
observing changes
-
comparing cycles
-
trying to interpret patterns
“I’m basically figuring it out as I go.”
– Mira survey participant
GLP-1 medications are no longer just a metabolic conversation. It has, in many ways, become a real-time experiment – happening in each individual body.
GLP-1 may intersect with:
-
hormones
-
ovulation
-
fertility
-
cycle health
And at the center of it – uncertainty.
Because the same change can mean different things: improvement, disruption, or simply variation.
Where tracking can help bring clarity
The Mira Hormone Monitor is designed to support women in understanding hormone patterns over time.
For those who are starting GLP-1, currently using it, or noticing changes tracking can offer a clearer view of what’s happening with fertility hormones cycle-to-cycle.
What this can look like:
-
observing hormone patterns across cycles
-
identifying ovulation patterns over time
-
comparing cycles before and during GLP-1 use
-
noticing trends, not just single changes
Important context:
-
Tracking is observational, not diagnostic
-
Hormonal changes can have multiple causes
-
GLP-1 is one of several factors that may influence patterns
The goal is not to explain why — but to help you capture what’s changing.
Final thought
For many women, this isn’t just about weight loss.
It’s about understanding their body – in a moment of change.
And maybe that’s the real shift: from asking “Is this normal?” to asking “What is my body showing me?”
